Waters Kevin
Known title: EVP, CFOCIK: 0001653771
Associated companies
Transaction History
| PRCT | ▼ Sell | Open Market | 373 | $8K | 9/9/2026 | View on chart |
| PRCT | ▲ Buy | Grant | 29,527 | $0 | 8/13/2026 | View on chart |
| PRCT | ▼ Sell | Open Market | 357 | $10K | 6/8/2026 | View on chart |
| PRCT | ▼ Sell | Open Market | 706 | $20K | 3/17/2026 | View on chart |
| PRCT | ▼ Sell | Open Market | 6,721 | $159K | 3/6/2026 | View on chart |
| PRCT | ▲ Buy | Grant | 47,462 | $0 | 3/5/2026 | View on chart |
| PRCT | ▲ Buy | Grant | 3,532 | $0 | 2/19/2026 | View on chart |
| PRCT | ▼ Sell | Open Market | 733 | $42K | 3/18/2025 | View on chart |
| PRCT | ▼ Sell | Open Market | 3,662 | $225K | 3/6/2025 | View on chart |
| PRCT | ▲ Buy | Grant | 16,290 | $0 | 3/3/2025 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 25,000 | $114K | 10/15/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 15,959 | $1.2M | 10/15/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 8,115 | $593K | 10/15/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 926 | $68K | 10/15/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 15,917 | $72K | 9/16/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 9,083 | $41K | 9/16/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 6,623 | $543K | 9/16/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 17,977 | $1.5M | 9/16/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 400 | $33K | 9/16/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 1,024 | $50K | 3/18/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 17,747 | $81K | 3/15/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 36,010 | $163K | 3/15/2024 | View on chart |
| PRCT | ▲ Buy | Grant | 19,328 | $0 | 3/6/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 3,435 | $160K | 3/6/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 22,349 | $101K | 2/12/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 22,349 | $1.1M | 2/12/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 28,677 | $1.4M | 2/9/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 28,677 | $130K | 2/9/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 904 | $4K | 2/7/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 904 | $45K | 2/7/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 17,310 | $78K | 1/9/2024 | View on chart |
| PRCT | ▼ Sell | Open Market | 17,310 | $780K | 1/9/2024 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 71,465 | $323K | 12/13/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 71,465 | $2.9M | 12/13/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 6,888 | $276K | 12/8/2023 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 6,888 | $31K | 12/8/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 3,837 | $153K | 12/7/2023 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 3,837 | $17K | 12/7/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 4,360 | $174K | 12/6/2023 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 4,360 | $20K | 12/6/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 22,631 | $795K | 6/15/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 706 | $22K | 3/16/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 22,046 | $758K | 3/8/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 7,136 | $244K | 3/7/2023 | View on chart |
| PRCT | ▼ Sell | Open Market | 818 | $29K | 3/7/2023 | View on chart |
| PRCT | ▲ Buy | Grant | 26,315 | $0 | 2/16/2023 | View on chart |
| PRCT | ▲ Buy | Grant | 7,914 | $233K | 3/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
PROCEPT BioRobotics Sets Q3 2026 Earnings Date for Nov 4
PROCEPT BioRobotics has announced it will release its third-quarter 2026 financial results on November 4, 2026. This scheduled update provides investors with a specific date to review the company's recent performance. The announcement serves as a standard corporate disclosure ahead of the earnings release.
PROCEPT BioRobotics Sets Q3 2026 Earnings Date for Nov 4. PROCEPT BioRobotics has announced it will release its third-quarter 2026 financial results on November 4, 2026. This scheduled update provides investors with a specific date to review the company's recent performance. The announcement serves as a standard corporate disclosure ahead of the earnings release.